Rep. Doggett: Making a Headline, Not a Difference - Statement on Trump Order on Drug Manufacturing
August 07, 2020
August 07, 2020
WASHINGTON, Aug. 7 -- Rep. Lloyd Doggett, D-Texas, issued the following statement on Aug. 6:
* * *
U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, reacted to President Trump's executive order on manufacturing today:
"Failing to lower drug prices after almost four years in office, Trump uses legitimate concerns about Big Pharma's overdependence on foreign sources as an excuse to continue weakening environ . . .
* * *
U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, reacted to President Trump's executive order on manufacturing today:
"Failing to lower drug prices after almost four years in office, Trump uses legitimate concerns about Big Pharma's overdependence on foreign sources as an excuse to continue weakening environ . . .